Skip to content

Investigator

Yu Chen

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · funded by NIA, NCI, NIAID

Companies
1

Resolved onto their grants.

Grants
11

Federal awards on file.

Non-dilutive funding
$10M

Summed across those awards.

First award
Sep 14, 2001

Latest Mar 1, 2026.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. K99

    Mapping cerebellar influence in FTD: unraveling the role of the cerebellum in social cognition and clinical trajectory

    $120k

    Mar 1, 2026NIAUNIVERSITY OF CALIFORNIA, SAN FRANCISCONIH RePORTER · 11283615 (opens the source filing in a new tab)

  2. R01

    A prospective study of viral infections and subsequent risk of Alzheimer’s disease

    $713k

    Feb 1, 2026NIANEW YORK UNIVERSITY SCHOOL OF MEDICINENIH RePORTER · 11229846 (opens the source filing in a new tab)

  3. R01

    Midlife circulating autoantibodies and the risk of Alzheimer’s disease in Women

    $725k

    Jan 1, 2026NIANEW YORK UNIVERSITY SCHOOL OF MEDICINENIH RePORTER · 11304392 (opens the source filing in a new tab)

  4. U01

    A prospective study of circulating autoantibodies and breast cancer risk in the NYU Women’s Health Study

    $703k

    Sep 1, 2025NCINEW YORK UNIVERSITY SCHOOL OF MEDICINENIH RePORTER · 11044553 (opens the source filing in a new tab)

  5. R01

    Defining the role of histone H3K4 mono-methyltransferase dysfunction in urothelial carcinoma

    $1.2M

    Sep 1, 2025NCISLOAN-KETTERING INST CAN RESEARCHNIH RePORTER · 11144600 (opens the source filing in a new tab)

  6. R01

    Clostridioides difficile Zinc-binding PBPs as anti-sporulation targets

    $2.9M

    Aug 1, 2025NIAIDUNIVERSITY OF SOUTH FLORIDANIH RePORTER · 11234622 (opens the source filing in a new tab)

  7. R01

    Exposure to Metal-Mixtures and Coronary Heart Disease Across Diverse Populations

    $692k

    Sep 24, 2024NIEHSNEW YORK UNIVERSITY SCHOOL OF MEDICINENIH RePORTER · 11196717 (opens the source filing in a new tab)

  8. SC3

    Iodine Catalyzed Cross-Coupling Reactions

    $116k

    Jun 15, 2022NIGMSQUEENS COLLEGENIH RePORTER · 11092123 (opens the source filing in a new tab)

  9. R01

    Evolution and inhibition of carbapenemase in beta-lactam resistance

    $779k

    Apr 6, 2021NIAIDUNIVERSITY OF SOUTH FLORIDANIH RePORTER · 11051272 (opens the source filing in a new tab)

  10. P50

    SPORE in Prostate Cancer

    $2.1M

    Sep 14, 2001NCISLOAN-KETTERING INST CAN RESEARCHNIH RePORTER · 11173716 (opens the source filing in a new tab)

  11. P50

    Core D: Preclinical Models Core

    $213k

    Sep 14, 2001NCISLOAN-KETTERING INST CAN RESEARCHNIH RePORTER · 11173744 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources